A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg.

Add to Collection

2022 Aug Others Y Seino, H Miyoshi, H Bosch Traberg… - Journal of Diabetes …, 2022 - Wiley Online Library 97

Full Author : ['Seino, Yutaka', 'Miyoshi, Hideaki', 'Bosch Traberg, Heidrun', 'Divyalasya, T V S', 'Nishijima, Keiji', 'Terauchi, Yasuo']
Journal Title : Journal of diabetes investigation
Chapter : Section3
Journal Year : 2022
Cited by : 1.0

AIMS/INTRODUCTION: The present trial compared the efficacy and safety of once-daily liraglutide 1.8 mg with liraglutide 0.9 mg in Japanese patients with type 2 diabetes to assess the incremental effects of liraglutide 1.8 mg in those who exhibited an inad..... Read More

Keywords : ["type diabetes exhibit", "oncedaily liraglutide mg", "liraglutide mg", "randomized trial", "japanese adult", "inadequate response", "safety", "investigate", "efficacy"]
PubMed Link : https://onlinelibrary.wiley.com/doi/abs/10.1111/jdi.13789
Google Scholar Link : https://scholar.google.com/scholar?cites=16619674205916440963&as_sdt=400005&sciodt=0,14&hl=en&num=20

Have a Question?

A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg.